323 related articles for article (PubMed ID: 17553306)
1. [Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up].
Gao LR; Wang ZG; Tian HT; Zhu ZM; Fei YX; Xu HT; Chen Y; Zhu JR; He S; Zhang NK; Ding QA; Yang Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):685-9. PubMed ID: 17553306
[TBL] [Abstract][Full Text] [Related]
2. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy.
Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y
Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443
[TBL] [Abstract][Full Text] [Related]
4. [Cardiomyoplasty with autological mononuclear cells of the bone marrow in patients with acute myocardial infarction].
Riabov VV; Suslova TE; Krylov AL; Poponina IuS; Vesnina ZhV; Sazonova SI; Markov VA; Popov SV; Karpov RS
Ter Arkh; 2006; 78(8):47-52. PubMed ID: 17078217
[TBL] [Abstract][Full Text] [Related]
5. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
6. [The autologous bone marrow mononuclear cell transplantation by intracoronary route treat patients with severe heart failure after myocardial infarction].
Gao LR; Tang CS; Zhu ZM; Wang ZG; Fei YX; Tian HT; Zhu JR; He S; Ding QA; Yang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):582-6. PubMed ID: 17081356
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.
Chen SL; Fang WW; Qian J; Ye F; Liu YH; Shan SJ; Zhang JJ; Lin S; Liao LM; Zhao RC
Chin Med J (Engl); 2004 Oct; 117(10):1443-8. PubMed ID: 15498362
[TBL] [Abstract][Full Text] [Related]
8. [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction].
Yao K; Huang RC; Ge L; Qian JY; Li YL; Xu SK; Zhang F; Zhang YQ; Niu YH; Shi JH; Zhang SH; Fan B; Wang QB; Sun AJ; Zou YZ; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):577-81. PubMed ID: 17081355
[TBL] [Abstract][Full Text] [Related]
9. The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI).
Li ZQ; Zhang M; Jing YZ; Zhang WW; Liu Y; Cui LJ; Yuan L; Liu XZ; Yu X; Hu TS
Int J Cardiol; 2007 Jan; 115(1):52-6. PubMed ID: 16822566
[TBL] [Abstract][Full Text] [Related]
10. The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.
Yousef M; Schannwell CM; Köstering M; Zeus T; Brehm M; Strauer BE
J Am Coll Cardiol; 2009 Jun; 53(24):2262-9. PubMed ID: 19520249
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
[TBL] [Abstract][Full Text] [Related]
12. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans.
Kuethe F; Richartz BM; Kasper C; Sayer HG; Hoeffken K; Werner GS; Figulla HR
Int J Cardiol; 2005 Apr; 100(3):485-91. PubMed ID: 15837094
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up after transepicardial implantation of autologous bone marrow mononuclear cells to ungraftable coronary territories for patients with ischaemic cardiomyopathy.
Akar AR; Durdu S; Arat M; Kilickap M; Kucuk NO; Arslan O; Kuzu I; Ozyurda U
Eur J Cardiothorac Surg; 2009 Oct; 36(4):633-43. PubMed ID: 19524451
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary administration of autologous bone marrow mononuclear cells in patients with chronic ischemic symptomatic cardiomyopathy: 5 years follow-up.
Blatt A; Minha S; Moravsky G; Vered Z; Krakover R
Isr Med Assoc J; 2010 Dec; 12(12):738-41. PubMed ID: 21348401
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary administration of autologous bone marrow mononuclear cells after induction of short ischemia is safe and may improve hibernation and ischemia in patients with ischemic cardiomyopathy.
Blatt A; Cotter G; Leitman M; Krakover R; Kaluski E; Milo-Cotter O; Resnick IB; Samuel S; Gozal D; Vered Z; Slavin S; Shapira MY
Am Heart J; 2005 Nov; 150(5):986. PubMed ID: 16290982
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow cells for myocardial repair-a new therapeutic concept.
Shah VK; Desai AJ; Vasvani JB; Desai MM; Shah BP; Lall TK; Mashru MR; Shalia KK; Tanavde V; Desai SS; Jankharia BJ
Indian Heart J; 2007; 59(6):482-90. PubMed ID: 19151463
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
[TBL] [Abstract][Full Text] [Related]
20. [Intracoronary autologous bone marrow-derived stem cell transplantation in patients with ischemic cardiomyopathy: results of 18-month follow-up].
Tayyareci Y; Umman B; Sezer M; Beşişik S; Sanli Y; Mudun A; Gürses N; Nişanci Y
Turk Kardiyol Dern Ars; 2008 Dec; 36(8):519-29. PubMed ID: 19223717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
